Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-02-24
1996-12-10
Clardy, S. Mark
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
436 64, 436 86, A61K 3808, G01N 3368, G01N 3374
Patent
active
055831109
ABSTRACT:
A method for screening for cancer, a cancer test, a screening system a patient monitoring system and medicinal dosage form for measuring stimulating a specific, detectable response from a stimulus-responsive neoplasm, comprising administering a neoplasm-affecting treatment, in sufficient quantity to stimulate the response; and drawing a blood sample at a time after administration sufficient to distinguish the response. Administering a GnRH analog to a woman prior to measuring circulating serum tumor markers for ovarian epithelial carcinoma provides an improved screening result.
REFERENCES:
Waxman et al. British Med. J. 291:1387-1388. Nov. 1985.
Conn et al. New England J. Med. 324(2):93-103. Jan. 1991.
Mayer et al. Obstetrics and Gynecology 75(3);529-531. Mar. 1990.
Barbot et al. "Pentagastrin Stimulation Test and Early Diagnosis of Medullary Thyroid Carcinoma . . . "J. Clin. Endocrinology and Metabolism. 78(1):114-120. 1994.
Leung et al. "Intercellular Signaling in thte Gonads", Endocrine Reviews. 13(3):476-498. Aug. 1992.
Ohno et al. "Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma", Am J Obstet Gynecol. 169(3): 605-611. 1993.
Adelson et al. "Effects of Gonadotropin-Releasing Hormone Analogues on Ovarian Epithelial Tumors", Clin. Obstetrics and Gynecology. 36(3):690-700. Sep. 1993.
Emons et al. "Gonadotropin Releasing Hormone Binding Sites in Human Epithelial Ovarian Carcinomata", Eur J Cancer Clin Oncol. 25:215-221. 1989 .
Altchek Albert
Balkin Michael
Clardy S. Mark
Stein Mitchell A.
LandOfFree
Detection of neoplasms by hormonal tumor stimulation test does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of neoplasms by hormonal tumor stimulation test, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of neoplasms by hormonal tumor stimulation test will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-424207